ENTRADA
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Jan 2032: the §8 declaration of use).
Record
- Serial number
- 97330161
- Registration number
- 8096243
- Mark type
- Word mark
- Filed
- 25 Mar 2022
- Published for opposition
- 24 Jan 2023
- Registered
- 06 Jan 2026
- Next maintenance filing
- §8 declaration of use, due by 06 Jan 2032 (grace period to 06 Jul 2032)
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA
- Entrada Therapeutics, Inc., Boston, MA
- Entrada Therapeutics, Inc., Boston, MA
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 12 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 12 Dec 2025 — SU-EXAMINER'S AMENDMENT WRITTEN
- 22 Sept 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Sept 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Jun 2025 — NON-FINAL ACTION E-MAILED
- 26 Jun 2025 — SU - NON-FINAL ACTION - WRITTEN
- 28 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE